🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Passage Bio, Inc.

Passage Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

PBGM01, PBFT02, PBKR03, PBML04, PBAL05, PBCM06

Passage Bio, Inc. develops transformative therapies for central nervous system diseases using proprietary genetic medicine technologies to deliver functional genes for the treatment of various disorders.

Tags: AAVhu68, central nervous system, genetic medicines, proprietary technology, therapies

Symbol: PASG

Recent Price: $0.67

Industry: Biotechnology

CEO: Dr. William Chou M.D.

Sector: Healthcare

Employees: 58

Address: One Commerce Square, Philadelphia, PA 19103

Phone: 267 866 0311

Leadership

  • William Chou, MD, President and Chief Executive Officer
  • Kathleen Borthwick, Chief Financial Officer
  • Sue Browne, PhD, Chief Scientific Officer
  • Edgar B. (Chip) Cale, General Counsel and Corporate Secretary
  • Eden Fucci, SVP Technical Operations
  • Stuart Henderson, Chief Business Officer
  • Karl Whitney, PhD, SVP Global Regulatory Affairs
  • James M. Wilson, MD, PhD, Scientific Advisor
  • Maxine Gowen, PhD, Chairwoman
  • Athena Countouriotis, MD,
  • Derrell D. Porter, MD,
  • Dolan Sondhi, PhD,
  • Sandip Kapadia,
  • Tom Kassberg,
  • Saqib Islam,
  • Samiah Al-Zaidy, MD, Vice President, Clinical Development
  • Andrea Campanile, Vice President, Clinical Operations

Last updated: 2024-12-31